HIGH PRETREATMENT ABSOLUTE LYMPHOCYTE COUNT PREDICTS INFERIOR OUTCOMES IN NK/T-CELL LYMPHOMA PATIENTS TREATED WITH PD-1 INHIBITORS: DEVELOPMENT AND VALIDATION OF A NOVEL PROGNOSTIC MODEL

EHA Library, Xindi Liu, 4208705

PRIMARY THYROID LYMPHOMA: CLINICAL FEATURES AND OUTCOME ANALYSIS IN A MULTICENTRIC RETROSPECTIVE ITALIAN STUDY

EHA Library, Mariella Lo Schirico, 4208706

12 YEARS UPDATE ON OVERALL SURVIVAL IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) TREATED WITH HIGH-DOSE CHEMOTHERAPY AND TEMOZOLOMIDE

EHA Library, Maher Salamoon, 4208708

SAFETY AND PRELIMINARY EFFICACY OF GOLIDOCITINIB COMBINED WITH POMALIDOMIDE IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (JACKPOT25): A MULTICENTER, PHASE I/II STUDY

EHA Library, Peng Sun, 4208709

CLINICAL FEATURES, TREATMENTS AND OUTCOME OF PLASMABLASTIC LYMPHOMA: RESULTS FROM A PRELIMINARY ANALYSIS OF THE RETROSPECTIVE INTERNATIONAL PLALY STUDY ON BEHALF OF FIL, LEO/MER REGISTRY AND PLRG

EHA Library, Emanuele Ravano, 4208710

MEASURABLE RESIDUAL DISEASE (MRD) BY CIRCULATING TUMOR (CT) DNA IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL) TREATED WITH LISOCABTAGENE MARALEUCEL (LISO-CEL) IN TRANSCEND FL

EHA Library, Franck Morschhauser, 4208713

GENOME-WIDE MUTATIONAL SIGNATURES REVEAL STAGE-SPECIFIC MUTAGENESIS ACROSS B-CELL MALIGNANCIES

EHA Library, Hui Wan, 4208714

SINGLE-CELL TRANSCRIPTOMIC PROFILING UNCOVERS THE PANORAMIC LANDSCAPE OF HETEROGENEOUS TUMOR CELLS AND IMMUNE MICROENVIRONMENT ACROSS DISEASE STAGES IN EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, Yun Dai, 4208717

LONGITUDINAL CTDNA DYNAMICS AROUND CAR-T CELL THERAPY AND THEIR IMPACT ON TREATMENT EFFICACY IN LARGE B-CELL LYMPHOMA.

EHA Library, Carolina Martinez Laperche, 4208719

INTEGRATIVE MULTI-OMICS ANALYSIS OF MICRORNA REGULATION IN RICHTER TRANSFORMATION

EHA Library, Julien Broseus, 4208724

TUMOR EVOLUTION AND IMMUNE MICROENVIRONMENT DYNAMICS IN PRIMARY AND RELAPSED MANTLE CELL LYMPHOMA

EHA Library, Hui Wan, 4208725

SH3GL1 ACTIVATE GLYCOLYTIC GENE PFKFB4 TO PROMOTES H3K18LA MODIFICATION IN DIFFUSE LARGE B-CELL LYMPHOMA PATHOGENESIS

EHA Library, Jinhua Liang, 4208727

PROFILING ANTIGEN REACTIVITY OF TUMOR B-CELL RECEPTORS DERIVED FROM HBV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Rui Sun, 4208729

TH22-LIKE SIGNATURE OF CD4+ T CELLS IS ASSOCIATED WITH RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE IN A MOUSE MODEL OF ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Linda Gräßel, 4208731

SPATIAL NICHE ORGANIZATION IMPLICATES ANTIGEN-PRESENTING–LIKE EPITHELIAL CELLS AS AN ACTIVE COMPONENT OF THE GASTRIC MALT LYMPHOMA MICROENVIRONMENT

EHA Library, Miki Joyce, 4208732

OVERLAYING TP53 LOSS AND ANEUPLOIDY WITH DISTINCT DIFFUSE LARGE B-CELL LYMPHOMA SUBTYPES REFINES TUMOR CLASSIFICATION AND ENHANCES RISK STRATIFICATION

EHA Library, Nikita Kotlov, 4208739

CD20-POSITIVE EXTRACELLULAR VESICLES ACT AS ANTIGEN DECOYS AND REDUCE RITUXIMAB ACTIVITY IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Seok Jin Kim, 4208741

DECIPHERING THE SPATIAL ARCHITECTURE OF PRIMARY BREAST DLBCL: IDENTIFICATION OF ECTOPIC MICROGLIA AND SPECIALIZED BOUNDARY IMMUNE HUBS

EHA Library, Chaowei Zhang, 4208743

TARGETING CD49D SYNERGIZES WITH ACD3/ACD20 BSAB IN A NOVEL AGGRESSIVE TRANSPLANTABLE DLBCL MOUSE MODEL WITH EXTENSIVE BONE MARROW INVOLVEMENT.

EHA Library, Nicolas Aubert, 4208744

FRAGMENTOMICS ANALYSIS TO ENHANCE CTDNA BASED RISK STRATIFICATION IN HODGKIN LYMPHOMA

EHA Library, Jessica Schneider, 4208745

MECHANISMS OF BCOR MUTATION IN PROMOTING RESISTANCE TO ANTI-PD-1 THERAPY IN NK/T-CELL LYMPHOMA

EHA Library, Linna Cheng, 4208746

DECITABINE RESCUES ANTIGEN PRESENTATION IN EBV-POSITIVE B-CELL LYMPHOMA THROUGH TFAP2A-DEPENDENT MHC-I REACTIVATION

EHA Library, Le Wang, 4208748

PLASMA PROTEOMIC PROFILING OF CLASSICAL HODGKIN LYMPHOMA IDENTIFIES DISTINCT INFLAMMATORY PROTEIN PROFILES

EHA Library, Ragnhild Risebro, 4208749

EPIGENETIC SILENCING OF MIR-146A-5P DRIVES RESISTANCE TO BTK INHIBITORS IN MANTLE CELL LYMPHOMA

EHA Library, Nir Cohen, 4208750

BIOLOGIC CORRELATES OF LONG‑TERM RESPONSE AFTER BREXUCABTAGENE AUTOLEUCEL THERAPY IN MANTLE CELL LYMPHOMA: PRODUCT PHENOTYPE, PK, AND BASELINE FEATURES

EHA Library, Marie José Kersten, 4208752

INTEGRATIVE MOLECULAR CHARACTERIZATION OF HIGH-GRADE/LARGE B-CELL LYMPHOMA WITH 11Q ABERRATION

EHA Library, Vicente Arredondo Prats, 4208753

SINGLE-CELL ATLAS OF PCNSL REVEALS A BCR-DOMINANT SIGNALING ARCHITECTURE AND UPREGULATION OF CD79B: A BIOLOGICAL RATIONALE FOR CD79B-DIRECTED THERAPIES

EHA Library, Byung Woo Yoon, 4208754

SINGLE-CELL ANALYSIS AND FUNCTIONAL PROFILING REVEAL GALECTIN-3–DRIVEN REPROGRAMMING OF THE TUMOR IMMUNE MICROENVIRONMENT IN TRANSFORMED FOLLICULAR LYMPHOMA

EHA Library, Xiaohui Wang, 4208755

THE MICROBIOME-LYMPHOMA AXIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF GUT DYSBIOSIS PATTERN IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Sarah Elkorashy, 4208757

PERIPHERAL CIRCULATING IMMUNE CELL SUBSETS: PROGNOSTIC VALUE AND CORRELATION WITH CLINICAL FEATURES IN TREATMENT-NAIVE DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Li LI, 4208758

BROAD MULTI-TARGET INFLAMMATORY MARKER SILENCING IN A TRANSLATIONAL MODELLING OF OCULAR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Alessia Cavalleri, 4208761

6-GINGEROL AMELIORATES CHRONIC GRAFT-VERSUS-HOST DISEASE BY REGULATING TREG/TH17 TRANSDIFFERENCIATION

EHA Library, Yuxuan He, 4208765

PRE-TRANSPLANT HIGH-DOSE METHOTREXATE AND INTENSIFIED INTRATHECAL PROPHYLAXIS DO NOT REDUCE CNS RELAPSE IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ni Lu, 4208768

STEM CELL MOBILIZATION IMPAIRMENT AFTER DARATUMUMAB-BASED QUADRUPLET INDUCTION IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY

EHA Library, Claudia Biosca, 4208771

REDUCED-DOSE ANTI-THYMOCYTE GLOBULIN PLUS MINI-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR GVHD PREVENTION IN HAPLOIDENTICAL DONOR HCT FOR HEMATOLOGIC MALIGNANCY

EHA Library, ZHANG YAUNYUAN, 4208775

MATCHED SIBLING DONOR TRANSPLANTATION FOR THALASSEMIA MAJOR: A LONG-TERM STUDY EVALUATING ATG FORMULATIONS AND THIOTEPA IN THE CONDITIONING REGIMEN

EHA Library, QIHONG LIN, 4208776

A PHASE 2 TRIAL OF MYELOABLATIVE FRACTIONATED BUSULFAN, FLUDARABINE, CLADRIBINE, THIOTEPA, AND VENETOCLAX (CLADILLAC) CONDITIONING FOR HIGH-RISK MDS

EHA Library, Uday R. Popat, 4208783

COMPARISON BETWEEN CHIDAMIDE, CLADRIBINE, GEMCITABINE AND BUSULFAN AS CONDITIONING REGIMEN AND BEAM FOR HIGH RISK NON-HODGKIN LYMPHOMA: A PROPENSITY SCORE MATCH ANALYSIS

EHA Library, Pu Kuang, 4208784

OUTCOMES AFTER STANDARD- VS. REDUCED-DOSE TREOSULFAN IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Johanne Schovsbo, 4208785

PROGNOSTIC ANALYSIS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ZNF384-REARRANGED ACUTE LEUKEMIA: A SINGLE-CENTER STUDY

EHA Library, Yue Lu, 4208787

LINEAGE-SPECIFIC CHIMERISM ANALYSIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) IN LYMPHOPROLIFERATIVE DISORDERS: EVOLUTION, OUTCOMES AND IMPACT OF DONOR LYMPHOCYTE INFUSIONS

EHA Library, Jesus Feliu, 4208790

ALLO-HSCT OVERCOME POOR PROGNOSIS IN PATIENTS WITH NUP98::NSD1-POSITIVE AML

EHA Library, hai he, 4208791

CAN QUANTIFERON CMV® PREDICT THE NEED FOR EXTENDED LETERMOVIR PROPHYLAXIS?

EHA Library, Milena Todorovic Balint, 4208793

SYSTEMIC TREATMENT WITH THE ROCK2 INHIBITOR BELUMOSUDIL IN OCULAR CHRONIC GRAFT VERSUS HOST DISEASE

EHA Library, Yibo Wu, 4208795

VENETOCLAX AND AZACITIDINE TREATMENT FOR HIGH RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA AS A BRIDGE THERAPY TO TRANSPLANT. REAL-LIFE EXPANDED GESMD STUDY.

EHA Library, Inés Zugasti, 4208799

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT FOR CHILDREN

EHA Library, Juan Xiao, 4208800

OPTIMAL DONOR DIRECTION IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION: OFFSPRING-TO-PARENT VERSUS PARENT-TO-OFFSPRING

EHA Library, Yu Wang, 4208801

EFFICACY AND SAFETY OF TOTAL BODY IRRADIATION COMBINED WITH THIOTEPA VERSUS TOTAL BODY IRRADIATION IN ALLO-HSCT FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA

EHA Library, MINGLU LI, 4208804

A NOVEL CLASSIFICATION OF ENGRAFTMENT SYNDROME AND ITS PROGNOSTIC IMPACT FOLLOWING HAPLOIDENTICAL ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Haixia Fu, 4208805

PREDICTORS OF CHEMORESISTANCE IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE STUDY FROM THREE FRENCH UNIVERSITY HOSPITALS

EHA Library, Aurélia Chacon, 4208707

AN INTEGRATIVE CLINICAL-IMMUNOGENETIC-GENOMIC INDEX (MCL-CIGI) IMPROVES THE RISK STRATIFICATION OF PATIENTS WITH MANTLE CELL LYMPHOMA

EHA Library, Ferran Nadeu, 4208711

CTPS1 PROMOTES DIFFUSE LARGE B-CELL LYMPHOMA PROGRESSION BY ENHANCING MITOPHAGY THROUGH CEPT1-MEDIATED PHOSPHOLIPID METABOLIC REMODELING

EHA Library, Jinhua Liang, 4208712

SPATIALLY ORGANIZED MACROPHAGE PHENOTYPES DEFINE TREATMENT RESPONSE IN AGGRESSIVE B-NHL

EHA Library, Christina Schniederjohann, 4208715

PET-GUIDED SINGLE-CELL PROFILING REVEALS MICROENVIRONMENT-DRIVEN METABOLIC HETEROGENEITY IN UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Danqing Zhao, 4208716

EARLY TUMOR-INFORMED CTDNA MONITORING IMPROVES RISK STRATIFICATION AFTER CAR-T THERAPY IN LARGE B-CELL LYMPHOMA

EHA Library, Mariana Bastos-Oreiro, 4208718

DISSECTING THE REGULATORY MECHANISMS OF CD47 EXPRESSION AND ITS THERAPEUTIC TARGETING IN CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Yusuke Kubota, 4208720

ATP1B3 REGULATES ALDOC-MEDIATED FRUCTOSE METABOLISM IN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Jinhua Liang, 4208721

SPATIAL PROTEOMICS IDENTIFIES T CELL CENTERED SPATIAL PATTERNS IN HIGH-RISK MANTLE CELL LYMPHOMA BY THE MULTIPLY CONSORTIUM

EHA Library, Sarah Koziel, 4208722

SINGLE-CELL AND SPATIAL TRANSCRIPTOMICS ANALYSIS OF PRIMARY CNS LYMPHOMA

EHA Library, Cong Wang, 4208723

CIRCULATING TUMOR DNA BASED MOLECULAR TUMOR BURDEN DYNAMICS IN A REAL-WORLD COHORT OF PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Santiago Barrio, 4208726

INTEGRATED GENOMIC AND TRANSCRIPTOMIC PROFILING REVEALS DISTINCT MECHANISMS IN EARLY- AND LATE-ONSET PT-DLBCL

EHA Library, Ana-Lucía Rocha, 4208728

CTDNA SEQUENCING REVEALS MUTATIONAL SIGNATURES WITH PROGNOSTIC RELEVANCE IN LBCL PATIENTS

EHA Library, Sven Borchmann, 4208730

THE MSZ REGIMEN (SELINEXOR, HIGH-DOSE METHOTREXATE, AND ZANUBRUTINIB) IN CENTRAL NERVOUS SYSTEM LYMPHOMA: A PHASE II TRIAL WITH NOVEL CNS PHARMACOKINETIC PROFILING

EHA Library, Li LI, 4208733

SYNERGY BETWEEN REL DEREGULATION AND TNFRSF14/HVEM LOSS IN THE TRANSFORMATION OF GERMINAL CENTER B CELLS

EHA Library, Karima Ferhat, 4208734

CLONAL HEMATOPOIESIS IS ASSOCIATED WITH PERSISTING ANEMIA IN ELDERLY PATIENTS TREATED FOR DLBCL: ANALYSIS OF THE PHASE 3 POLAR BEAR TRIAL

EHA Library, Simon Husby, 4208735

ST6GALNAC4 DRIVES DLBCL PROGRESSION BY SIALYLATING LDHA TO ENHANCE GLYCOLYSIS

EHA Library, Anqi Zhou, 4208736

SPATIAL TRANSCRIPTOMICS REVEALS GENE EXPRESSION PATTERNS ASSOCIATED WITH BONE MARROW INVOLVEMENT OF FOLLICULAR LYMPHOMA

EHA Library, Gabriella Szepesi, 4208737

GENOMIC DETERMINANTS OF RESPONSE AND RESISTANCE TO ZANUBRUTINIB IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA: BASELINE BIOMARKER ANALYSIS FROM THE PRIZM+ TRIAL

EHA Library, Donatella Talotta, 4208738

ESTABLISHING ADDITIONAL PATIENT-DERIVED LYMPHOMA XENOGRAFTS AND CELL LINES OF LARGE B-CELL LYMPHOMA: GENETIC, TRANSCRIPTIONAL, AND FUNCTIONAL RELEVANCE, AND APPLICABILITY FOR PRECLINICAL RESEARCH

EHA Library, Alexandra Dolnikova, 4208740

ALTERED CHROMATIN PATTERNING AS A PREDISPOSING FACTOR FOR ERRONEOUS REARRANGEMENTS IN B-CELL LYMPHOMAS

EHA Library, Prakruti Uday, 4208742

COMPOSITION AND PROGNOSTIC IMPACT OF TP53 ALTERATIONS ACROSS MATURE B-CELL NEOPLASMS: CLONE SIZE OF MUTATION AND DEL(17P) BOTH MATTER

EHA Library, Veronika Ecker, 4208747

CLINICAL AND BIOLOGICAL CHARACTERISTICS OF MATURE AGGRESSIVE B-CELL LYMPHOMA IN ADOLESCENTS AND YOUNG ADULTS USING MULTICENTER REGISTRY DATA IN JAPAN

EHA Library, Yasuhiro Suzuki, 4208751

GERM LAYER SPECIFICATION AND ORGANOTROPISM IN LYMPHOMA INVASION

EHA Library, Muchen Zhang, 4208756

RECIPIENT-ORIGINATED MACROPHAGES REGULATE ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Sisi Zhen, 4208760

MICROBIOTA METABOLITE PHENLYACETYLGLYCINE ALLEVIATES ACUTE GRAFT-VERSUS-HOST DISEASES

EHA Library, Wang Yuqing, 4208762

DECODING THE GVL/GVHD PARADOX IN HSCT : A MULTI-OMICS APPROACH FOR SELECTIVE IMMUNOTHERAPY

EHA Library, Romane Bariseel, 4208763

CDCP1+ MESENCHYMAL STEM CELLS PREFERENTIALLY INHIBIT ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)

EHA Library, Lun Yan, 4208764

LETERMOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE RESULTS OF LETREAL STUDY.

EHA Library, Yi Xia, 4208767

EFFICACY OF CAR-T BRIDGING TO ALLO-HSCT IN ADULT TCF3::PBX1+ ALL: IMPACT OF INFUSION FREQUENCY

EHA Library, Jingyu Wang, 4208769

CLINICAL APPLICATION OF DUAL-TARGET STRATEGY OF NUTRITION AND MICROBIOTA IN HIGH-RISK PATIENTS UNDERGOING TRANSPLANTATION

EHA Library, Shashali Shasha, 4208770

DONOR-DERIVED DNMT3A MUTATIONS: SUBTYPE, CLONAL BURDEN AND TRANSPLANTATION OUTCOMES AFTER ALLOGENEIC HSCT

EHA Library, jiawei zhao, 4208772

DOSE OPTIMIZATION OF ANTI-T LYMPHOCYTE GLOBULIN IN HAPLOIDENTICAL HSCT: A PROSPECTIVE RANDOMIZED NON-INFERIORITY TRIAL

EHA Library, Yigeng Cao, 4208773

CD7 CAR-T THERAPY AS A BRIDGE TO ALLO-HSCT IN R/R T-ALL/LBL: POST-TRANSPLANT PERSISTENCE OF DONOR-DERIVED CAR-T CELLS PREDICTS POOR OUTCOME

EHA Library, Zhihui Li, 4208774

REAL-WORLD USE OF POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SURVEY FROM THE CTIWP OF EBMT

EHA Library, Shlomo Elias, 4208777

EARLY CHEMO INDUCED-CARDIOTOXICITY DETECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jiexian Ma, 4208779

POST-TRANSPLANT CYCLOPHOSPHAMIDE DOSE MODULATION BASED ON AGE, COMORBIDITIES AND CARDIOVASCULAR RISK FACTORS: RESULTS FROM A PROSPECTIVE PILOT STUDY.

EHA Library, Cristina Skert, 4208780

A RETROSPECTIVE STUDY EVALUATING THE ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME INITIALLY DIAGNOSED AS LOWER RISK

EHA Library, Alexandre Bazinet, 4208781

BELUMOSUDIL IN PEDIATRIC PATIENTS WITH STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Lipeng Liu, 4208782

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CD19 CAR-T CELL THERAPY FOR CENTRAL NERVOUS SYSTEM LYMPHOMA: A CLINICAL EFFICACY AND SAFETY ANALYSIS

EHA Library, Xudong Zhang, 4208786

LATE RELAPSE RISK AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN KMT2A -REARRANGED ACUTE MYELOID LEUKEMIA- A 20% INCIDENCE BEYOND TWO YEARS.

EHA Library, Yasir Jeelani, 4208788

UPFRONT ALLOGENEIC STEM CELL TRANSPLANTATION USING ARCHIVE CONDITIONING IN ACUTE MYELOID LEUKEMIA

EHA Library, Andrius Žučenka, 4208789

MEASURABLE RESIDUAL KMT2A PARTIAL TANDEM DUPLICATION BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Lulu Wang, 4208792

AXATILIMAB IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED SAFETY ANALYSIS OF A RANDOMIZED PHASE 2 STUDY

EHA Library, Robert Zeiser, 4208794

STUDY ON THE DIFFERENCE OF FINE IMMUNE INDEXES OF DIFFERENT CONDITIONING REGIMENS IN MICROTRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA

EHA Library, Lijuan Li, 4208796

DIFFERENTIAL TOXICITY AND IMMUNE RECONSTITUTION PROFILES OF BEAM-ATG VS. CYCLOPHOSPHAMIDE-ATG IN MULTIPLE SCLEROSIS

EHA Library, Christian Koch, 4208797

FACTORS PREDICTING RELAPSE AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN SYSTEMIC DIFFUSE LARGE B-CELL LYMPHOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A FINNISH MULTICENTER STUDY

EHA Library, Lotta Ravattinen, 4208798

SALVAGE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONHODGKIN LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Linwei Shi, 4208802

DONOR SELECTION IN HAPLOIDENTICAL ALLOGENEIC TRANSPLANTATION: THE ROLE OF RECIPIENT AGE AND KINSHIP.

EHA Library, Nisham Pandikasala Narikuth, 4208803

AZACITIDINE PLUS VENETOCLAX AS POST-TRANSPLANT MAINTENANCE THERAPY IN HIGH-RISK MYELOID MALIGNANCIES: A PROPENSITY SCORE-MATCHED ANALYSIS

EHA Library, xinxin Xia, 4208806

CLINICAL IMPLICATIONS OF SUSTAINED HYPOBARIC HYPOXIA ON NEUTROPHIL ENGRAFTMENT AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yigeng Cao, 4208807